Skip to main content

Animations

MJFF Publications

1641 - 1650 of 6324 Results
Title
Year
  • Year
  • 2012
  • 2014
  • 2011
  • 2018
  • 2009
  • 2013
  • 2017
  • 2015
  • 2018
  • 2015
  • Summary Details
    OPEN
    Title: Discovery of Potent, Novel Nrf2 Inducers Via Quantum Modeling, Virtual Screening, and In Vitro Experimental Validation
    Journal Name: Chemical Biology & Drug Design
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/cbdd.12040
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein
    Journal Name: Applied Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/app4010066
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1012500108
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Increasing the use of mobile technology–derived endpoints in clinical trials
    Journal Name: Clinical Trials
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1740774518755393
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2008.12.007
    Citation Count: 222
  • Summary Details
    OPEN
    Title: Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.02.016
    Citation Count: 141
  • Summary Details
    OPEN
    Title: Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2017.09.012
    Citation Count: 140
  • Summary Details
    OPEN
    Title: Dysrhythmia of timed movements in Parkinson׳s disease and freezing of gait
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2015.07.041
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-018-0349-z
    Citation Count: 31
  • Summary Details
    OPEN
    Title: The microbiome of the human lower airways: a next generation sequencing perspective
    Journal Name: World Allergy Organization Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s40413-015-0074-z
    Citation Count: 43
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.